Engineered Heart Tissue: High Throughput Platform for Dissection of Complex Diseases

ArticleinJournal of Cardiovascular Translational Research 1(3):232-5 · September 2008with10 Reads
Impact Factor: 3.02 · DOI: 10.1007/s12265-008-9026-0 · Source: PubMed

    Abstract

    The polygenic nature of resistance/sensitivity of the heart to ischemia is generally accepted. Unfortunately, little is known about gene(s) involved in response to this insult. The goal of present study is to introduce new tool, engineered heart tissue (EHT), for accelerating positional cloning and for providing novel functional assays.